Tacrolimus- and sirolimus-induced human β cell dysfunction is reversible and preventable
Chunhua Dai(Diabetes Australia), Alvin C. Powers(Vanderbilt University Medical Center), Dale L. Greiner(University of Massachusetts Chan Medical School), Ana Padgett(Diabetes Australia), Shawn Levy(HudsonAlpha Institute for Biotechnology), Leonard D. Shultz(Jackson Laboratory), Rita Bottino(Children's Hospital of Pittsburgh), Greg Poffenberger(Vanderbilt University Medical Center), Erick Spears(Diabetes Australia), Alena Shostak(Vanderbilt University Medical Center), Nripesh Prasad(Life Sciences Discovery Fund), Radhika Aramandla(Vanderbilt University Medical Center), John T. Walker(Vanderbilt University), Scott Wisniewski(Diabetes Australia), E. Danielle Dean(Vanderbilt University Medical Center)
Cited by 62
Related Papers
Human Lymphoid and Myeloid Cell Development in NOD/LtSz- <i>scid IL2R</i> γ <i>null</i> Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,
|The Journal of Immunology|2005|1.7k
Production of α1,3-Galactosyltransferase-Deficient Pigs
|Science|2003|1.1k
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
|Science|2015|980